IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

IL-8/CXCL8 Upregulates 12-Lipoxygenase Expression in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats

  • Kim, Jung-Hae (Department of Microbiology, College of Medicine, Yeungnam University) ;
  • Kang, Young-Jin (Department of Parmacology and Aging-associated Vascular Disease Research Center, College of Medicine, Yeungnam University) ;
  • Kim, Hee-Sun (Department of Microbiology, College of Medicine, Yeungnam University)
  • Received : 2009.05.07
  • Accepted : 2009.05.26
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: We previously demonstrated remarkable differences in the expression of IL-8/CXCL8 in aortic tissues and vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) compared to VSMC from normotensive Wistar-Kyoto rats (WKY). In the present study, we investigated the direct effect of IL-8/CXCL8 on expression of 12-lipoxygenase (LO), a hypertensive modulator, in SHR VSMC. Methods: Cultured aortic VSMC from SHR and WKY were used. Expression of 12-LO mRNA was determined by real-time polymerase chain reaction. Phosphorlyation of ERK1/2 and production of 12-LO and angiotensin II subtype 1 ($AT_1$) receptor were assessed by Western blots. IL-8/CXCL8-stimulated DNA synthesis was determined by measuring incorporation of [$^3H$]-thymidine. And effect of IL-8/CXCL8 on vascular tone was determined by phenylephrine-induced contraction of thoracic aortic rings. Results: Treatment with IL-8/CXCL8 greatly increased 12-LO mRNA expression and protein production compared to treatment with angiotensin II. IL-8/CXCL8 also increased the expression of the $AT_1$ receptor. The increase in 12-LO induced by IL-8/CXCL8 was inhibited by treatment with an $AT_1$ receptor antagonist. The induction of 12-LO mRNA production and the proliferation of SHR VSMC by IL-8/CXCL8 was mediated by the ERK pathway. The proliferation of SHR VSMC and the vascular contraction in the thoracic aortic ring, both of which were induced by IL-8/CXCL8, were inhibited by baicalein, a 12-LO inhibitor. Conclusion: These results suggest that the potential role of IL-8/CXCL8 in hypertensive processes is likely mediated through the 12-LO pathway.

Keywords

References

  1. Alexander RW: Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25;155-161, 1995 https://doi.org/10.1161/01.HYP.25.2.155
  2. Capers Q 4th, Alexander RW, Lou P, De Leon H, Wilcox JN, Ishizaka N, Howard AB, Taylor WR: Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30;1397-1402, 1997 https://doi.org/10.1161/01.HYP.30.6.1397
  3. Zhang Y, Griendling KK, Dikalova A, Owens GK, Talyor WR: Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived $H_2O_2$. Hypertension 46;732-737, 2005 https://doi.org/10.1161/01.HYP.0000182660.74266.6d
  4. Rodríguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ: Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: all for one and one for all. Am J Physiol 286;F606-F616, 2004 https://doi.org/10.1152/ajprenal.00269.2003
  5. Dhungana S, Sharrack B, Woodroofe N: Cytokines and chemokines in idiopathic intracranial hypertension. Headache 49;282-285, 2009 https://doi.org/10.1111/j.1526-4610.2008.001329.x
  6. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding MA, Gimbrone MA, Luster AD, Luscinskas FW, Rosenzweig A: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398;718-723, 1999 https://doi.org/10.1038/19546
  7. Boekholdt S, Peters R, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT: IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol 24;1503-1508, 2004 https://doi.org/10.1161/01.ATV.0000134294.54422.2e
  8. Kim HY, Kang YJ, Song IH, Choi HC, Kim HS: Upregulation of IL-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 31;515-523, 2008 https://doi.org/10.1291/hypres.31.515
  9. Natarajan R, Rosdahl J, Gonzales N, Bai W: Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells. Hypertension 30;873-879, 1997 https://doi.org/10.1161/01.HYP.30.4.873
  10. Preston IR, Hill NS, Warburton RR, Fanburg BL: Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation. Am J Lung Cell Mol Physiol 290;L367-L374, 2006 https://doi.org/10.1152/ajplung.00114.2005
  11. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L: Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 22;3595-3606, 2008 https://doi.org/10.1096/fj.08-112201
  12. Reddy MA, Sahar S, Villeneuve LM, Lanting L, Natarajan R: Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 29;387-393, 2009 https://doi.org/10.1161/ATVBAHA.108.179150
  13. Natarajan R, Gu JL, Rossi J, Gonzales N, Lanting L, Xu L, Nadler J: Elevated glucose angiontensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci USA 90;4947-4951, 1993 https://doi.org/10.1073/pnas.90.11.4947
  14. Kim JA, Gu JL, Natarajan R, Rerliner JA, Nadler JL: A leukocyte type 12-lipoxygenase is expressed in human vascular and mononuclear cells: Evidence for upregulation by angiotensin II. Arterioscler Thromb Vasc Biol 15;942-948, 1995 https://doi.org/10.1161/01.ATV.15.7.942
  15. Sasaki M, Hori MT, Hino T, Golub MS, Tuck ML: Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat. Am J Hypertens 10;371-378, 1997
  16. Yue TL, Wang X, Sung CP: Interleukin-8: a mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 75;1-7, 1994 https://doi.org/10.1161/01.RES.75.1.1
  17. Usui M, Egashira K, Tomita H, Koyanagi M, Katoh M, Shimokawa H, Takeya M, Yoshimura T, Matsushima K, Takeshita A: Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation 101;305-310, 2000 https://doi.org/10.1161/01.CIR.101.3.305
  18. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl AK, Thaiss F: Angiotensin II activates nuclear transcription factor-κB through $AT_1$ and $AT_2$ receptors. Kidney Int 61;1986-1995, 2002 https://doi.org/10.1046/j.1523-1755.2002.00365.x
  19. Siragy HM: AT1 and AT2 receptors in the kidney: Role of disease and treatment. Am J Kidney Dis 36(Suppl 1);S4-S9, 2000
  20. Horiuchi M, Akishita M, Dzau VJ: Recent progress in angiotensin II Type 2 receptor research in the cardiovascular system. Hypertension 33;613-621, 1999 https://doi.org/10.1161/01.HYP.33.2.613
  21. Jin XQ, Fukuda N, Lai YM, Suzuki R, Tahira Y, Takgi H, Ikeda Y, Kanmatsuse K, Miyazaki H: Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension 39;1021-1027, 2002 https://doi.org/10.1161/01.HYP.0000016179.52601.B4
  22. Reddy MA, Adler SG, Kim YS, Lanting L, Rossi J, Kang SW, Nadler JL, Shahed A, Natarajan R: Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol 283;F985-F994, 2002 https://doi.org/10.1152/ajprenal.00181.2002
  23. Buemi M, Marino D, Floccari F, Ruello A, Nostro L, Aloisi C, Marino MT, Pasquale G, Corica F: Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of $K^+$ in eryth rocytes from subjects with essential hypertension. Curr Med Res Opin 20;19-24, 2004 https://doi.org/10.1185/030079903125002720
  24. Ohkawa F, Ikeda U, T Kanbe, Kawasaki K, Shimada K: Effects of inflammatory cytokines on vascular tone. Cardiovasc Res 30;711-715, 1995 https://doi.org/10.1016/S0008-6363(95)00101-8

Cited by

  1. Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats vol.34, pp.12, 2009, https://doi.org/10.1038/hr.2011.132
  2. Reparixin, an Inhibitor of CXCR1 and CXCR2 Receptor Activation, Attenuates Blood Pressure and Hypertension-Related Mediators Expression in Spontaneously Hypertensive Rats vol.34, pp.1, 2009, https://doi.org/10.1248/bpb.34.120
  3. Recombinant human CXCL8(3-72)K11R/G31P regulates smooth muscle cell proliferation and migration through blockage of interleukin-8 receptor vol.65, pp.1, 2009, https://doi.org/10.1002/iub.1107
  4. CCL5 Inhibits Elevation of Blood Pressure and Expression of Hypertensive Mediators in Developing Hypertension State Spontaneously Hypertensive Rats vol.45, pp.2, 2009, https://doi.org/10.4167/jbv.2015.45.2.138
  5. Heat shock protein 60 stimulates the migration of vascular smooth muscle cells via Toll-like receptor 4 and ERK MAPK activation vol.5, pp.None, 2009, https://doi.org/10.1038/srep15352
  6. Des-aspartate angiotensin I (DAA-I) reduces endothelial dysfunction in the aorta of the spontaneously hypertensive rat through inhibition of angiotensin II-induced oxidative stress vol.71, pp.None, 2015, https://doi.org/10.1016/j.vph.2015.03.011
  7. Hypertensive effects of transforming growth factor-β1 in vascular smooth muscles cells from spontaneously hypertensive rats are mediated by sulfatase 2 vol.150, pp.None, 2009, https://doi.org/10.1016/j.cyto.2021.155754